home / stock / rani / rani news

RANI News and Press, Rani Therapeutics Holdings Inc.

Stock Information
Company Name: Rani Therapeutics Holdings Inc.
Stock Symbol: RANI
Market: NASDAQ
Website: ranitherapeutics.com
Menu
RANI RANI Quote RANI Short RANI News RANI Articles RANI Message Board
Get RANI Alerts

News, Short Squeeze, Breakout and More Instantly...
RANI - Rani Therapeutics enters into partnership with ProGen for oral obesity treatment

2024-06-24 07:12:15 ET More on Rani Therapeutics Rani Therapeutics reports Q1 results Seeking Alpha’s Quant Rating on Rani Therapeutics Historical earnings data for Rani Therapeutics Financial information for Rani Therapeutics Read the full a...
RANI - Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

~ New RT-114 obesity program combines ProGen’s FC Fusion protein conjugated GLP-1/GLP-2 dual agonist, PG-102, with the RaniPill® capsule designed to provide a differentiated oral delivery mechanism with bioavailability comparable to subcutaneous injection ~ ~ Rani and Pr...

RANI - When (RANI) Moves Investors should Listen

2024-05-16 19:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

RANI - Rani Therapeutics to Participate in May Investor Conferences

SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will parti...
RANI - Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it will present clinic...

RANI - Rani Therapeutics reports Q1 results

2024-05-07 10:47:42 ET More on Rani Therapeutics Rani Therapeutics Holdings, Inc. (RANI) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Rani Therapeutics Historical earnings data for Rani Therapeutics Financial information for Rani Th...

RANI - Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

- Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) - - Initiation of Phase 2 clinical trial for RT-102 for the treatment of osteoporosis expected in 2024 - - RaniPill HC to be ready for potential Phase 1 clinical tria...
RANI - Learn to Evaluate (RANI) using the Charts

2024-04-27 16:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

RANI - BGC, DRS and AMTX are among after hour movers

2024-04-19 17:56:39 ET Gainers: BGC Group ( BGC ) +8% . Taboola  ( TBLA ) +5% . Lam Research Corporation ( LRCX ) +4% . Kodiak Sciences  ( KOD ) +3% . Leonardo  ( DRS ) +3% . Losers: Rani Therapeutics ...

RANI - US Companies Moving the Markets, Evening edition
Wed, Apr 17, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 62.9% to $0.0373 on volume of 466,310,671 shares INVO BioScience Inc. (INVO) rose 139.5% to $1.82 on volume of 225,666,770 shares PROSHARES TRUST (SQQQ) rose 3.7% to $11.86 on volume of 167,545,988 ...
Next 10